Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3

Genome Biology

Volumn 13, Issue 9, 2012, Pages

  Frietze, Seth ^a   Wang, Rui ^b,c   Yao, Lijing ^a   Tak, Yu G ^a   Ye, Zhenqing ^c   Gaddis, Malaina ^a   Witt, Heather ^a   Farnham, Peggy J ^a   Jin, Victor X ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LANZHOU UNIVERSITY   (China)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HISTONE H3; LYSINE; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR GATA 3; FOXA2 PROTEIN, HUMAN; GATA3 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; TCF7L2 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; CELL ASSAY; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; GATA BINDING PROTEIN 3 GENE; GENE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC MARKER; GENOME ANALYSIS; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR PHYLOGENY; PROMOTER REGION; PROTEIN MOTIF; RNA ANALYSIS; SEQUENCE ANALYSIS; TRANSCRIPTION FACTOR 7 LIKE 2 GENE; ANTIBODY SPECIFICITY; CELL STRAIN HEK293; ENHANCER REGION; GENETIC TRANSCRIPTION; GENETICS; HUMAN GENOME; METABOLISM; NUCLEOTIDE MOTIF; PROTEIN BINDING; TUMOR CELL LINE;

BINDING SITES; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; GATA3 TRANSCRIPTION FACTOR; GENOME, HUMAN; HEK293 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; NUCLEOTIDE MOTIFS; ORGAN SPECIFICITY; PROTEIN BINDING; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 84865773113     PISSN: None     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2012-13-9-r52     Document Type: Article

References (51)

1. Poy F, Lepourcelet M, Shivdasani RA, Eck MJ. Structure of a human Tcf4-beta-catenin complex. Nat Struct Biol 2001, 8:1053-1057. 10.1038/nsb720, 11713476.
2. Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott LJ, Usher N, Tong M, Sprau A, Swift A, Bonnycastle LL, Erdos MR, He Z, Saxena R, Harmon B, Kotova O, Hoffman EP, Altshuler D, Groop L, Boehnke M, Collins FS, Hall JL. Tissue-specific alternative splicing of TCF7L2. Hum Mol Genet 2009, 18:3795-3804. 10.1093/hmg/ddp321, 2748888, 19602480.
3. Ravindranath A, O'Connell A, Johnston PG, El-Tanani MK. The role of LEF/TCF factors in neoplastic transformation. Curr Mol Med 2008, 8:38-50. 10.2174/156652408783565559, 18289012.
4. Roose J, Clevers H. TCF transcription factors: molecular switches in carcinogenesis. Biochem Biophys Acta 1999, 87456:M23-M37.
5. Shitashige M, Hirohashi S, Yamada T. Wnt signaling inside the nucleus. Cancer Sci 2008, 99:631-637. 10.1111/j.1349-7006.2007.00716.x, 18177486.
6. Grove EA. Wnt signaling meets internal dissent. Genes Dev 2011, 25:1759-1762. 10.1101/gad.17594311, 3175712, 21896652.
7. Gambino R, Bo S, Gentile L, Musso G, Pagano G, Cavallo-Perin P, Cassader M. Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult Italian population-based cohort. Diabetes Care 2010, 33:1233-1235. 10.2337/dc09-1690, 2875429, 20299486.
8. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323. 10.1038/ng1732, 16415884.
9. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segre AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42:579-589. 10.1038/ng.609, 3080658, 20581827.
10. Weedon MN. The importance of TCF7L2. Diabet Med 2007, 24:1062-1066. 10.1111/j.1464-5491.2007.02258.x, 17888129.
11. Blahnik KR, Dou L, O'Geen H, McPhillips T, Xu X, Cao AR, Iyengar S, Nicolet CM, Ludaescher B, Korf I, Farnham PJ. Sole-search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res 2010, 38:e13. 10.1093/nar/gkp1012, 2817454, 19906703.
12. Zhao J, Schug J, Li M, Kaestner KH, Grant SF. Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Diabetologia 2010, 53:2340-2346. 10.1007/s00125-010-1852-3, 20640398.
13. Trompouki E, Bowman TV, Lawton LN, Fan ZP, Wu DC, DiBiase A, Martin CS, Cech JN, Sessa AK, Leblanc JL, Li P, Durand EM, Mosimann C, Heffner GC, Daley GQ, Paulson RF, Young RA, Zon LI. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 2011, 147:577-589. 10.1016/j.cell.2011.09.044, 3219441, 22036566.
14. Zhou Y, Zhang E, Berggreen C, Jing X, Osmark P, Lang S, Cilio CM, Goransson O, Groop L, Renstrom E, Hansson O. Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway. Hum Mol Genet 2012, 21:196-207. 10.1093/hmg/ddr454, 21965303.
15. Norton L, Fourcaudot M, Abdul-Ghani MA, Winnier D, Mehta FF, Jenkinson CP, Defronzo RA. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia 2011, 54:3132-3142. 10.1007/s00125-011-2289-z, 21901280.
16. Osmark P, Hansson O, Jonsson A, Ronn T, Groop L, Renstrom E. Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia 2009, 52:850-854. 10.1007/s00125-009-1293-z, 19247628.
17. Weise A, Bruser K, Elfert S, Wallmen B, Wittel Y, Wohrle S, Hecht A. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets. Nucleic Acids Res 2010, 38:1964-1981. 10.1093/nar/gkp1197, 2847248, 20044351.
18. Hansson O, Zhou Y, Renstrom E, Osmark P. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes. Curr Diab Rep 2010, 10:444-451. 10.1007/s11892-010-0149-8, 20878273.
19. Le Bacquer O, Shu L, Marchand M, Neve B, Paroni F, Kerr Conte J, Pattou F, Froguel P, Maedler K. TCF7L2 splice variants have distinct effects on beta-cell turnover and function. Hum Mol Genet 2011, 20:1906-1915. 10.1093/hmg/ddr072, 21357677.
20. Locke JM, Da Silva Xavier G, Rutter GA, Harries LW. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes. Diabetologia 2011, 54:3078-3082. 10.1007/s00125-011-2290-6, 3210366, 21913056.
21. Cuilliere-Dartigues P, El-Bchiri J, Krimi A, Buhard O, Fontanges P, Flejou JF, Hamelin R, Duval A. TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene 2006, 25:4441-4448. 10.1038/sj.onc.1209471, 16547505.
22. Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 2000, 60:3872-3879.
23. Frietze S, Lan X, Jin VX, Farnham PJ. Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem 2010, 285:1393-1403. 10.1074/jbc.M109.063032, 2801265, 19887448.
24. Lan X, Bonneville R, Apostolos J, Wu W, Jin VX. W-ChIPeaks: a comprehensive web application tool for processing ChIP-chip and ChIP-seq data. Bioinformatics 2011, 27:428-430. 10.1093/bioinformatics/btq669, 3031039, 21138948.
25. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837. 10.1016/j.cell.2007.05.009, 17512414.
26. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alverez P, Brockman W, Kim T-K, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560. 10.1038/nature06008, 2921165, 17603471.
27. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh T-Y, Peng W, Zhang MQ, Zhao K. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008, 40:897-903. 10.1038/ng.154, 2769248, 18552846.
28. Jin V, Apostolos J, Nagisetty NS, Farnham PJ. W-ChIPMotifs: a web application tool for de novo motif discovery from ChIP-based high throughput data. Bioinformatics 2009, 25:3191-3193. 10.1093/bioinformatics/btp570, 2778340, 19797408.
29. Jin VX, O'Geen H, Iyengar S, Green R, Farnham PJ. Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches. Genome Res 2007, 17:807-817. 10.1101/gr.6006107, 1891340, 17567999.
30. Hatzis P, van der Flier LG, van Driel MA, Guryev V, Nielsen F, Denissov S, Nijman IJ, Koster J, Santo EE, Welboren W, Versteeg R, Cuppen E, van de Wetering M, Clevers H, Stunnenberg HG. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 2008, 28:2732-2744. 10.1128/MCB.02175-07, 2293123, 18268006.
31. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010, 38:576-589. 10.1016/j.molcel.2010.05.004, 2898526, 20513432.
32. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382:638-642. 10.1038/382638a0, 8757136.
33. Fasolini M, Wu X, Flocco M, Trosset JY, Oppermann U, Knapp S. Hot spots in Tcf4 for the interaction with beta-catenin. J Biol Chem 2003, 278:21092-21098. 10.1074/jbc.M301781200, 12657632.
34. Hecht A, Stemmler MP. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J Biol Chem 2003, 278:3776-3785. 10.1074/jbc.M210081200, 12446687.
35. Hansen T, Ingason A, Djurovic S, Melle I, Fenger M, Gustafsson O, Jakobsen KD, Rasmussen HB, Tosato S, Rietschel M, Frank J, Owen M, Bonetto C, Suvisaari J, Thygesen JH, Petursson H, Lonnqvist J, Sigurdsson E, Giegling I, Craddock N, O'Donovan MC, Ruggeri M, Cichon S, Ophoff RA, Pietilainen O, Peltonen L, Nothen MM, Rujescu D, St Clair D, Collier DA, et al. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry 2011, 70:59-63. 10.1016/j.biopsych.2011.01.031, 21414605.
36. Nateri A, Spencer-Dene B, Behrens A. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 2005, 437:281-285. 10.1038/nature03914, 16007074.
37. Hoffman BG, Robertson G, Zavaglia B, Beach M, Cullum R, Lee S, Soukhatcheva G, Li L, Wederell ED, Thiessen N, Bilenky M, Cezard T, Tam A, Kamoh B, Birol I, Dai D, Zhao Y, Hirst M, Verchere CB, Helgason CD, Marra MA, Jones SJ, Hoodless PA. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res 2010, 20:1037-1051. 10.1101/gr.104356.109, 2909568, 20551221.
38. Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475:390-393. 10.1038/nature10263, 21716291.
39. Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S. GATA switches as developmental drivers. J Biol Chem 2010, 285:31087-31093. 10.1074/jbc.R110.159079, 2951181, 20670937.
40. Brewer A, Pizzey J. GATA factors in vertebrate heart development and disease. Expert Rev Mol Med 2006, 8:1-20.
41. Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it!. J Cell Physiol 2010, 222:42-49. 10.1002/jcp.21943, 2915440, 19798694.
42. Patient RK, McGhee JD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 2002, 12:416-422. 10.1016/S0959-437X(02)00319-2, 12100886.
43. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 2008, 13:141-152. 10.1016/j.ccr.2008.01.011, 2262951, 18242514.
44. Kouros-Mehr H, Kim JW, Bechis SK, Werb Z. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 2008, 20:164-170. 10.1016/j.ceb.2008.02.003, 2397451, 18358709.
45. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 2010, 285:14042-14051. 10.1074/jbc.M110.105262, 2859565, 20189993.
46. Blauwkamp TA, Chang MV, Cadigan KM. Novel TCF-binding sites specify transcriptional repression by Wnt signalling. EMBO J 2008, 27:1436-1446. 2396397, 18418383.
47. Verzi MP, Hatzis P, Sulahian R, Philips J, Schuijers J, Shin H, Freed E, Lynch JP, Dang DT, Brown M, Clevers H, Liu XS, Shivdasani RA. TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc Natl Acad Sci USA 2010, 107:15157-15162. 10.1073/pnas.1003822107, 2930576, 20696899.
48. Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011, 25:2227-2241. 10.1101/gad.176826.111, 3219227, 22056668.
49. O'Geen H, Echipare L, Farnham PJ. Using ChIP-Seq technology to generate high-resolution profiles of histone modifications. Methods Mol Biol 2011, 791:265-286. 10.1007/978-1-61779-316-5_20, 21913086.
50. O'Geen H, Frietze S, Farnham PJ. Using ChIP-seq technology to identify targets of zinc finger transcription factors. Methods Mol Biol 2010, 649:437-455. 10.1007/978-1-60761-753-2_27, 20680851.
51. Blahnik KR, Dou L, Echipare L, Iyengar S, O'Geen H, Sanchez E, Zhao Y, Marra MA, Hirst M, Costello JF, Korf I, Farnham PJ. Characterization of the contradictory chromatin signatures at the 3' exons of zinc finger genes. PLOS One 2011, 6:e17121. 10.1371/journal.pone.0017121, 3039671, 21347206.